Dr. Roberto Leon-Ferre

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Mayo Clinic experts discuss breast cancer research that may reduce or eliminate the need for chemotherapy and endocrine treatments that may allow for shorter, less intense radiation courses.

People with early-stage triple-negative breast cancer and high levels of immune cells in their tumors may have a lower risk of recurrence and better survival rates.